Home Digestive Disorders IBD: Ulcerative Colitis What’s Health Canada Saying about Biosimilars?

IBD: Ulcerative Colitis

What’s Health Canada Saying about Biosimilars?

Tags: ,

A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!

This video was made possible by an unrestricted educational grant by Pfizer Canada. 

Related Articles

Living Positively with Ulcerative Colitis Webinar
Living Positively with Ulcerative Colitis Webinar

Tags:

On June 26th CDHF sat down with three individuals who have been diagnosed with ulcerative colitis (UC) to learn all about what it is like to […]

Read More

IBD: Crohn’s Disease

Tags:

Read More

IBD: Switching from a Biologic to a Biosimilar
IBD: Switching from a Biologic to a Biosimilar

Tags: ,

Updated March 2021 Having to change any kind of medication can be very stressful. While CDHF believes in patient-physician choice, we acknowledge political policy decisions and […]

Read More

What’s Health Canada Saying about Biosimilars?

https://www.youtube.com/watch?v=6DkzQFdyNuY
A biosimilar biologic drug, or biosimilar, is a drug demonstrated to be highly similar to a biologic drug that was already authorized for sale (known as the reference biologic drug).  Biosimilars are approved based on a thorough comparison to a reference drug and may enter the market after the expiry of reference drug patents and data protection. Watch this video to get more insight into what Health Canada is saying about biosimilars!